LS
WST icon

Livforsakringsbolaget Skandia’s West Pharmaceutical WST Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Hold
512
– – 0.01% 394
2025
Q4 		$141K Hold
512
– – 0.01% 407
2025
Q3 		$134K Sell
512
-100
-16% -$24.3K 0.01% 433
2025
Q2 		$134K Hold
612
– – 0.01% 453
2025
Q1 		$137K Hold
612
– – 0.01% 455
2024
Q4 		$200K Buy
+612
New +$193K 0.01% 393
2024
Q3 		– Sell
-190
Closed -$62.6K – 615
2024
Q2 		$62.6K Hold
190
– – 0.01% 350
2024
Q1 		$75.1K Hold
190
– – 0.01% 346
2023
Q4 		$66.9K Buy
190
+90
+90% +$31.9K 0.01% 356
2023
Q3 		$37.5K Hold
100
– – ﹤0.01% 358
2023
Q2 		$38.2K Hold
100
– – ﹤0.01% 370
2023
Q1 		$34.6K Hold
100
– – ﹤0.01% 396
2022
Q4 		$23.5K Hold
100
– – ﹤0.01% 448
2022
Q3 		$25K Sell
100
-400
-80% -$122K ﹤0.01% 433
2022
Q2 		$151K Sell
500
-200
-29% -$65.1K 0.01% 386
2022
Q1 		$287K Hold
700
– – 0.02% 378
2021
Q4 		$328K Sell
700
-700
-50% -$301K 0.02% 372
2021
Q3 		$594K Hold
1,400
– – 0.04% 305
2021
Q2 		$503K Buy
1,400
+600
+75% +$198K 0.03% 349
2021
Q1 		$225K Hold
800
– – 0.02% 452
2020
Q4 		$227K Hold
800
– – 0.02% 434
2020
Q3 		$220K Hold
800
– – 0.02% 374
2020
Q2 		$182K Hold
800
– – 0.02% 404
2020
Q1 		$122K Buy
800
+200
+33% +$30.8K 0.02% 435
2019
Q4 		$90K Buy
+600
New +$87.4K 0.01% 537

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Livforsakringsbolaget Skandia's WST Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its West Pharmaceutical (WST) position steady in Q1 2026 at 512 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #394.

Livforsakringsbolaget Skandia first reported a position in WST in Q4 2019 and has held it in 25 quarters since. The position peaked at $594K in Q3 2021. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Livforsakringsbolaget Skandia held 512 shares of West Pharmaceutical worth $128K as of Q1 2026.
  • Livforsakringsbolaget Skandia left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #394 holding.
  • Livforsakringsbolaget Skandia first reported a position in West Pharmaceutical in Q4 2019 and has held it in 25 quarters since.
  • Livforsakringsbolaget Skandia's West Pharmaceutical position peaked at $594K in Q3 2021.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.